Antman

[Antman @Hope31224]

@ShitValueFund $SKK.ASX outperform upgrade again today….

[StockWire X | ASX News @StockWireX]

$13.55M FY26 revenue recorded as @Stakk forecasts maiden operating profit and $21.8M FY27 outlook from executed contracts $SKK

https://t.co/aZ4DhCfai6

[Antman @Hope31224]

@toy59496 95,000 paid scans in the last quarter with no mention of free or research scans. They did more than 95,000 in just one reverse study of historical records.

[Ron Shamgar @RonShamgar]

No position here BUT arguably $EIQ is a better play than the larger and different business in $4DX

but in this case $PME wants to sell and integrate $EIQ product into its stack !!

They didn’t want that with $4DX 👀

[Kalkine Media Australia @kalkineau]

EchoIQ is gaining attention in the ASX small-cap space for its AI-driven cardiac diagnostics, reflecting broader market interest in healthcare innovation and artificial intelligence applications.
https://t.co/7ogZdbUb6s
#EchoIQ #ASX #SmallcapIndex #AI #KalkineMediaAU #PennyStock

[Antman @Hope31224]

@longhorncapital @pastperformerAU $EIQ is already FDA approved from the same database but HF is the flagship…. They have been smart by testing the system for approval with AS first

[Rudi Filapek-Vandyck @Filapek]

RBC Capital: "PME and EIQ have entered into a binding Heads of Agreement (HOA) which will allow PME to distribute EchoSolve HF, an AI-powered heart failure detection software, in exchange for an A$10m upfront investment and an optional A$10m tranche upon FDA clearance.

"A strategically logical partnership, in our opinion, with initial analysis suggesting Visage and EchoSolve as complementary platforms - Visage serving as the imaging and workflow layer and EchoSolve serving as the AI-driven diagnostic intelligence layer on top.

"EIQ noted that the partnership provides a working capital bridge to FDA clearance (with last 4Q reporting ~4.2 quarter of cash remaining) while simultaneously providing access to PME's network of tier-1 US health systems and eliminating the need to build a direct sales force.

"For PME, the deal delivers both an economic interest and a product that deepens its cardiology value proposition through the embedding of an AI diagnostic capability directly onto Visage.

"Ultimately, a small investment here for PME with significant optionality: strategic upside if EchoSolve HF clears the FDA and gains traction across PME's hospital network for an immaterial ~A$20m investment."
$PME $EIQ #stocksinfocus #equities #XJO #investing

[Antman @Hope31224]

@David_McMahon75 @cryptojesus69 Desperately trying to keep the NDIS votes alive!

[Antman @Hope31224]

@ShitValueFund @asxpeasant

[MARKETS FULL OF R3TARD5 @ShitValueFund]

Now 3.2c and going for glory on this one

[Antman @Hope31224]

36% $SKK 🚀…..

[Antman @Hope31224]

$SKK .asx again! You little beauty!

[Antman @Hope31224]

@mascarosergi Cettire has just announced New business partnership in China with Tmall….

Probably also explains why the went up 5 places globally to the 10th largest online luxury goods eretailer recently

[Pigeon @CheatChart]

$SKK - 2.4 cents, DYOR

[StockWire X | ASX News @StockWireX]

Mount Sinai Health — No. 2 US cardiology hospital — deploys @echoiq_ai EchoSolv AS across seven hospitals $EIQ

https://t.co/9jV38eFwrZ

[Australian FinTech @austfintech]

ASX-listed Stakk reports $5.36 million in receipts and positive cash flows, signalling inflection in revenue conversion

https://t.co/2vU5QDMaO3 #australianfintech #usfintech #fintech #fintechnews #financialtechnology #finance #receipts #revenue #growth #cashflow

[Small Caps @SmallCapsASX]

Xenitra ($XEN) says OPAL tokenised EZZ sales hit $100k in week one, onboarding 20+ distributors under a $10m global distribution deal.

#ASX #SmallCaps #XEN

https://t.co/pOaG37azj9

[StockWire X | ASX News @StockWireX]

$100,000 in week-one sales as @Xenitra launches OPAL token ecosystem with 20+ distributors onboarded $XEN

https://t.co/DXPHU0ji1F

[Samso Research @Samso_Insights]

$EIQ https://t.co/sgPheNLmAa Echo IQ Ltd (ASX: EIQ) The biggest challenge in AI? Data. It's the new oil, Exclusive access to one of the world's best datasets is the competitive moat, making these models significantly better. Can another AI compete? Unlikely, without the same data access, says @EchoIQ_US #Data #Tech #AI #healthcare

[Antman @Hope31224]

@asxpeasant Don’t miss $SKK ….. you put me on this one when it was $DOU ….

Don’t think any of us saw it running like this…. $EIQ is showing no signs of slowing down….